Medicare targets non-mail order diabetes supply payments
WASHINGTON, June 22, 2012—The Centers for Medicare & Medicaid Services (CMS) has scheduled a public meeting for July 23 to discuss adjustments in Medicare payments for non-mail order diabetes supplies through a controversial “inherent reasonableness” process.
The process is being triggered by competitive bidding prices on mail-order diabetes supplies that were about half that paid by Medicare at retail stores. Essentially, CMS now wants to set prices for non-mail order diabetes supplies indirectly through the competitive bidding process.
The meeting is planned for 9 a.m.-1 p.m. ET at CMS, 7500 Security Blvd., Baltimore, Md., 21244. For information on registration go to the CMS document. For more information on the public hearing, go to the notice in the Federal Register.